Late Breaking Abstract - Effects of a Novel Dual Phosphodiesterase 3 and 4 Inhibitor TQC3721 in Patients with COPD in China (PACER-II): a phase 2, multicentre, randomised, double-blind, placebo-controlled trial
Year: 2025
Type: conference-abstract
Source: European Respiratory Journal
Authors: Zhu Luo, Li Xiu He, Ling Yang, Weiguo Li, Ding Yu, Weimin Li
Institutions: Sichuan University, West China Hospital of Sichuan University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4416638148